Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) leading to elevated adverse effects such as drowsiness, although the medical relevance is small in most patients – keep track of the individual for adverse effects (e. The objective of this research was To https://medeusresearchchem.com/product-category/research-chemicals/